Altoida Inc (Altoida) is a provider of digital biomarker technology. The company offers AI platform and software medical devices for cognitive assessment testing, monitoring and diagnosis of brain health and neurological diseases such as Alzheimer's at early stages. Its platform uses smartphone and tablet sensors for measuring neurocognitive domains. The company works in collaboration with therapeutics and research companies such as Novartis, Takeda, Lilly, Eisai, and Click Therapeutics, among others. Altoida is headquartered in Washington, Washington D.C., the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Altoida Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Altoida Inc Company Overview
- Altoida Inc Company Snapshot
- Altoida Inc Pipeline Products and Ongoing Clinical Trials Overview
- Altoida Inc - Pipeline Analysis Overview
- Altoida Inc - Key Facts
- Altoida Inc - Major Products and Services
- Altoida Inc Pipeline Products by Development Stage
- Altoida Inc Ongoing Clinical Trials by Trial Status
- Altoida Inc Pipeline Products Overview
- Altoida Software Device - Alzheimer's Disease
- Altoida Software Device - Alzheimer's Disease Product Overview
- Altoida Software Device - Alzheimer's Disease Clinical Trial
- Altoida Software Device - Dementia
- Altoida Software Device - Dementia Product Overview
- Altoida Software Device - Parkinson's Disease
- Altoida Software Device - Parkinson's Disease Product Overview
- Altoida Inc - Key Competitors
- Altoida Inc - Key Employees
- Altoida Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Altoida Inc, Recent Developments
- Dec 19, 2023: Study Published in Nature Digital Medicine Shows Potential Predictive Power of Augmented Reality-based Cognitive and Functional Assessment for Alzheimer’s Disease
- Oct 19, 2023: Altoida to Present Poster Presentations Highlighting Augmented Reality-Based Cognitive Assessment at CTAD 2023
- Mar 20, 2023: Altoida announces upcoming poster presentations at AD/PD 2023
- Jun 15, 2022: Women’s Brain Project and Altoida announce results highlighting sex-based differences using predictive digital biomarker in Alzheimer’s Disease
- May 16, 2022: Altoida joins Digital Medicine Society’s (DiMe) Alzheimer's Disease and related dementias project to advance next-generation predictive biomarkers
- Feb 07, 2022: Altoida partners with GN Group to research and develop new cognitive assessment technology to detect mild cognitive impairment
- Oct 25, 2021: Altoida and Ionian University investigate breakthrough software device for Parkinson's disease diagnosis
- Oct 18, 2021: Altoida launches 5-Year Multi-Center Alzheimer’s study with Eisai and Ionian University
- Jul 06, 2021: Altoida secures funding and Research Partnership with Eisai Innovation
- Jul 06, 2021: Altoida secures funding and research partnership with Eisai innovation
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Altoida Inc Pipeline Products and Ongoing Clinical Trials Overview
- Altoida Inc Pipeline Products by Equipment Type
- Altoida Inc Pipeline Products by Indication
- Altoida Inc Ongoing Clinical Trials by Trial Status
- Altoida Inc, Key Facts
- Altoida Inc, Major Products and Services
- Altoida Inc Number of Pipeline Products by Development Stage
- Altoida Inc Pipeline Products Summary by Development Stage
- Altoida Inc Ongoing Clinical Trials by Trial Status
- Altoida Inc Ongoing Clinical Trials Summary
- Altoida Software Device - Alzheimer's Disease - Product Status
- Altoida Software Device - Alzheimer's Disease - Product Description
- Altoida Software Device - Alzheimer's Disease - Detecting an MCI and Amyloid Digital Neuro Signature(DNS) Using Altoida's Multimodal Digital Biomarkers
- Altoida Software Device - Dementia - Product Status
- Altoida Software Device - Dementia - Product Description
- Altoida Software Device - Parkinson's Disease - Product Status
- Altoida Software Device - Parkinson's Disease - Product Description
- Altoida Inc, Key Employees
- Glossary
- Altoida Inc Pipeline Products by Equipment Type
- Altoida Inc Pipeline Products by Development Stage
- Altoida Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BrainCheck Inc
- Cognivue Inc
- Savonix Inc
- BrainCheck Inc
- Cognivue Inc
- Savonix Inc
